Network News

How can artificial intelligence support medical imaging diagnostics in the future and significantly improve patient care? Researchers led by Lena Maier-Hein (German Cancer Research Center, DKFZ, and NCT Heidelberg) have developed an innovative concept to address this question. The Carl Zeiss-Stiftung is funding the MEDAL* project with a total of three million euros. Experts and […]

Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease Paris, March 18, 2026. The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to venglustat, a novel, investigational oral glucosylceramide synthase inhibitor (GCSi), for the treatment of neurological manifestations of type 3 Gaucher disease (GD3), a rare lysosomal storage disorder. The designation is based on […]

Ladenburg, Germany, 18 March 2026 – Heidelberg Pharma AG (FSE: HPHA), a clinical-stage biotech company developing innovative Antibody Drug Conjugates (ADCs), today announced that its partner Huadong Medicine Co., Ltd., Hangzhou, China, (SZ 000963; Huadong) has reached a development milestone under the terms of the license agreement from February 2022. With the dosing of the first patient […]

The University Children’s Hospital Zurich and the Thomas and Doris Ammann Foundation have awarded the Thomas and Doris Ammann Prize to Stefan Pfister, Director of the Hopp Children’s Cancer Center Heidelberg (KiTZ), Head of Department at the German Cancer Research Center (DKFZ), professor at the Heidelberg Medical Faculty of Heidelberg University, and pediatric oncologist at […]

Heidelberg, March 13, 2026 – Thursday, March 12, 2026, the boundaries of what is scientifically feasible and technically possible in cancer research were pushed further into the future: The approximately 130 participants at the GENESIS 26 – The LIFE SCIENCE TECH DAY forum hosted by InnovationLab GmbH did not merely content themselves with the scientific […]

Prof. Dr. Gudrun Rappold, senior professor at Heidelberg University’s Medical Faculty, has been awarded the Medal of Honor by the German Society for Human Genetics. The Medal of Honor is the highest award given by the professional association and recognizes outstanding scientific achievements in human genetics as well as special contributions to the advancement of […]

Rector Frauke Melchior: “A fantastic joint effort led to success” Heidelberg University has been successful in all previous rounds of the excellence competition and, in the current funding round, has convincingly defended its status as a University of Excellence. That announcement came today (Wednesday, 11 March 2026) from the German Science and Humanities Council and […]

[Munich, 10/03/2026] — FGK Clinical Research GmbH, a leading full-service Contract Research Organization (CRO) headquartered in Germany, is thrilled to announce the further expansion of its operative team in the Netherlands. This strategic regional expansion strengthens FGK’s European presence and commitment to high-quality clinical research services. The local Dutch team will support clinical studies in the […]

Ladenburg, Germany, 9 March 2026 – Heidelberg Pharma AG (FSE: HPHA), a clinical stage biotech company developing innovative Antibody Drug Conjugates (ADCs), announced on 7 March an additional amendment to its existing royalty purchase agreement with HealthCare Royalty (HCRx) and the participation of Soleus Capital Management, L.P. (Soleus Capital), a US-based life sciences investment firm, on behalf […]